Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Chemical glycobiology: why now?

Understanding the structure and function of carbohydrates remains a key challenge for chemical biologists. Developments in carbohydrate synthesis and analysis together with the advent of high-throughput methods such as carbohydrate microarrays have helped shed light on the function of glycoconjugates. Similarly, consortia have provided technology platforms and focus to a burgeoning field. Now, recruitment of scientists from related fields and further integration of chemistry and biology to achieve technical goals are needed for rapid advancements.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Carbohydrate complexity is a result of branching and the stereochemistry of the glycosidic linkage.
Figure 2: Strategies for carbohydrate synthesis.
Figure 3

References

  1. Kunz, H. Angew. Chem. Int. Ed. 41, 4439–4451 (2002).

    CAS  Article  Google Scholar 

  2. Varki, A. Glycobiology 3, 97–130 (1993).

    CAS  PubMed  Google Scholar 

  3. Seeberger, P.H. & Werz, D.B. Nature 446, 1046–1051 (2007).

    CAS  Article  PubMed  Google Scholar 

  4. Varki, A. et al. Essentials of Glycobiology (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA, 1999).

    Google Scholar 

  5. Boons, G.J. Carbohydrate Chemistry (Blackie Academic & Professional, Glasgow, Scotland, 1998).

    Google Scholar 

  6. Schmidt, R.R. Angew. Chem. Int. Edn Engl. 25, 212–235 (1986).

    Article  Google Scholar 

  7. Dell, A. & Morris, H.R. Science 291, 2351–2356 (2001).

    CAS  Article  PubMed  Google Scholar 

  8. Venkataraman, G., Shriver, Z., Raman, R. & Sasisekharan, R. Science 286, 537–542 (1999).

    CAS  Article  PubMed  Google Scholar 

  9. Plante, O.J., Palmacci, E.R. & Seeberger, P.H. Science 291, 1523–1527 (2001).

    CAS  Article  PubMed  Google Scholar 

  10. Sears, P. & Wong, C.-H. Science 291, 2344–2350 (2001).

    CAS  Article  PubMed  Google Scholar 

  11. Paulson, J.C., Blixt, O. & Collins, B.E. Nat. Chem. Biol. 2, 238–248 (2006).

    CAS  Article  PubMed  Google Scholar 

  12. Ohtsubo, K. & Marth, J.D. Cell 126, 855–867 (2006).

    CAS  Article  PubMed  Google Scholar 

  13. von der Lieth, C.-W. J. Carbohydr. Chem. 23, 277–297 (2004).

    CAS  Article  Google Scholar 

  14. Caruthers, M.H. Science 230, 281–285 (1985).

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

P.H.S. is a board member and major shareholder at Ancora Pharmaceuticals, a company he cofounded in 2003.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Seeberger, P. Chemical glycobiology: why now?. Nat Chem Biol 5, 368–372 (2009). https://doi.org/10.1038/nchembio0609-368

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio0609-368

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing